Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Value of Molten Ventures' holding in Revolut rises significantly

(Sharecast News) - Molten Ventures, a prominent venture capital firm known for investing in high-growth digital technology companies, announced a substantial increase in the valuation of its holding in fintech company Revolut on Wednesday. The FTSE 250 company said it followed a recent secondary share sale by Revolut, which valued the company at $45bn.

Based on the new valuation, Molten Ventures' stake in Revolut was now estimated at around £160m, marking a significant uplift of around £95m from the previous gross carrying value of £65m, recorded as of 31 March.

The impact on Molten Ventures' net asset value was yet to be adjusted for factors including carried interest, potential further valuation changes, and corporation tax on capital gains, which currently stands at 25%.

It said the adjustments would be finalised and reflected in its interim results for the period ending 30 September.

Molten Ventures said it would provide additional updates in a trading update ahead of the interim results.

"Revolut has recently gone from strength to strength," said Molten chief executive officer Martin Davis.

"It is great to see the business able to reward its people for their contribution to its growth, and at a valuation which provides significant upside to our own.

This shows the benefit to our investors of the prudent approach we take to net asset value, and we look forward to updating on the precise uplift in more detail when we next report results."

At 0851 BST, shares in Molten Ventures were up 2.28% at 404p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Berenberg lowers target price on Impax Asset Management
(Sharecast News) - Analysts at Berenberg lowered their target price on Impax Asset Management from 620.0p to 560.0p on Tuesday but noted that outflows had started to slow.
GSK's Arexvy provides protection over three RSV seasons, trial shows
(Sharecast News) - GSK has announced positive results from a phase III trial of its Arexvy RSV vaccine, showing that just one dose of the treatment could help protect older adults at risk of RSV disease over three seasons.
S&U revenue up, profitability a challenge in first half
(Sharecast News) - Motor and property finance specialist S&U reported a mixed first-half financial performance on Tuesday, after group revenue increased 9% year-on-year to £60.4m.
Loungers reports slight slowdown in LFL sales growth
(Sharecast News) - Cosy Club owner Loungers reported a slight slowdown in like-for-like sales growth on Tuesday and a jump in revenue.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.